Skip to main content
Premium Trial:

Request an Annual Quote

Prolexys and Ariadne to Integrate Software, Database

NEW YORK, Nov. 16 (GenomeWeb News) - Ariadne Genomics and Prolexys Pharmaceuticals will pair their pathway-analysis tools to target the pharmaceutical research market, the companies said today

 

Under the terms of the agreement, Prolexys' Human Interactome Database, a collection of experimentally verified human protein-protein interactions, will be integrated with Ariadne's PathwayStudio and PathwayExpert pathway-analysis software.


The Prolexys database will be available from Ariadne Genomics for an additional fee to its commercial customers, Prolexys and Ariadne said.

The Scan

Steps for Quick Review

The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal.

Moving Away From Using Term 'Race'

A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports.

Point of the Program

The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question.

Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation

In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.